跳至主要内容
临床试验/NCT04742140
NCT04742140已完成4 期

Magnesium Sulphate Injection in Treatment of Myofascial Trigger Points in Masseter Muscle

Fayoum University1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2021年2月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
180
试验地点
1
主要终点
pain score

研究概览

简要总结

This is a prospective, single- center, randomized (1:1) clinical trial comparing the effectiveness of magnesium sulphate injections in treatment of myofascial trigger points in the masseter muscle versus the saline injection.

详细描述

The proposal presents the magnesium sulphate (MgSO4) as a possible injection treatment for TrPs. The MgSO4 prevents the release of pre-synaptic acetylcholine from neuromuscular and sympathetic junctions that could explain the ability of the MgSO4 to relax the muscle and reduce pain Specific aim: evaluate the effectiveness of magnesium sulphate injections in treatment of myofascial trigger points in the masseter muscle versus the saline injection.

Hypothesis

the injection of masseter muscle trigger points with magnesium sulphate is more effective than saline injection in pain relief.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Definite diagnosis of myofascial pain with a referral, based on the DC/TMD criteria
  • the presence of one or more trigger points in the unilateral or bilateral masseter muscle
  • no history of any invasive procedures in the related masseter muscle.

排除标准

  • Factors that can cause pain in the orofacial region other than MTPs (decayed tooth, TMJ internal disorder).
  • Any systemic disease that possibly affects the masticatory system such as rheumatoid arthritis and epilepsy
  • pregnancy and lactation.

研究组 & 干预措施

group II

Experimental

each patient injected 0.5ml in each TrPs of magnesium sulphate by the same operator

干预措施: Magnesium sulfate (Drug)

group I

Active Comparator

each patient injected 0.5ml in each TrPs of saline by the same operator

干预措施: Saline (Drug)

结局指标

主要结局

pain score

时间窗: 6 months postoperative

pain score measured on a 10-point visual analogue scale (VAS), the 0 indicating no pain and 10 indicating the worst pain ever.

次要结局

  • quality-of-life in an Oral Health Impact Profile questionnaire (OHIP-14)(six months postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alshaimaa Ahmed shabaan

associate professor in oral & maxillofacial Surgery Department

Fayoum University

研究点 (1)

Loading locations...

相似试验